Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery.

[1]  M. Broch,et al.  Effect of weight loss induced by gastric bypass on proinflammatory interleukin‐18, soluble tumour necrosis factor‐α receptors, C‐reactive protein and adiponectin in morbidly obese patients , 2007 .

[2]  J. Gugenheim,et al.  Inflammation, insulin resistance, lipid disturbances, anthropometrics, and metabolic syndrome in morbidly obese patients: a case control study comparing laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy. , 2011, Surgery.

[3]  Heike Münzberg,et al.  Mechanisms of leptin action and leptin resistance. , 2008, Annual review of physiology.

[4]  U. Das.  Is obesity an inflammatory condition? , 2001, Nutrition.

[5]  M. Sjöström,et al.  The Human Visceral Fat Depot Has a Unique Inflammatory Profile , 2010, Obesity.

[6]  A. Fatiregun,et al.  HEALTH RISKS OF OBESITY , 2009, Annals of Ibadan postgraduate medicine.

[7]  C. Fox,et al.  BMI Modifies Associations of IL‐6 Genotypes with Insulin Resistance: The Framingham Study , 2006, Obesity.

[8]  S. Ikramuddin,et al.  Adipokine response in diabetics and nondiabetics following the Roux-en-Y gastric bypass: a preliminary study. , 2007, The Journal of surgical research.

[9]  L. Kuller,et al.  The Chronic Inflammatory Hypothesis for the Morbidity Associated with Morbid Obesity: Implications and Effects of Weight Loss , 2004, Obesity surgery.

[10]  D. Giugliano,et al.  Role of Adipokines in the Obesity–Inflammation Relationship: The Effect of Fat Removal , 2006, Plastic and reconstructive surgery.

[11]  P. Garcia-Lorda,et al.  Subcutaneous adipose tissue cytokine production is not responsible for the restoration of systemic inflammation markers during weight loss , 2006, International Journal of Obesity.

[12]  J. Gugenheim,et al.  Impact of Laparoscopic Roux-en-Y Gastric Bypass on Metabolic Syndrome, Inflammation, and Insulin Resistance in Super Versus Morbidly Obese Women , 2009, Obesity surgery.

[13]  S. Brichard,et al.  Induction of adiponectin in skeletal muscle by inflammatory cytokines: in vivo and in vitro studies. , 2004, Endocrinology.

[14]  R. Vettor,et al.  Adipocytokines, fat distribution, and insulin resistance in elderly men and women. , 2004, The journals of gerontology. Series A, Biological sciences and medical sciences.

[15]  W. Ricart,et al.  Effect of massive weight loss on inflammatory adipocytokines and the innate immune system in morbidly obese women. , 2007, The Journal of clinical endocrinology and metabolism.

[16]  M. Moreno-Aliaga,et al.  Regulation of adipokine secretion by n-3 fatty acids , 2010, Proceedings of the Nutrition Society.

[17]  H. Taegtmeyer,et al.  Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery. , 2009, The American journal of medicine.

[18]  C. Caruso,et al.  The Role of Adipose Tissue and Adipokines in Obesity-Related Inflammatory Diseases , 2010, Mediators of inflammation.

[19]  L. Heilbronn,et al.  Energy Restriction and Weight Loss on Very-Low-Fat Diets Reduce C-Reactive Protein Concentrations in Obese, Healthy Women , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[20]  M. Broch,et al.  Effect of weight loss induced by gastric bypass on proinflammatory interleukin-18, soluble tumour necrosis factor-alpha receptors, C-reactive protein and adiponectin in morbidly obese patients. , 2007, Clinical endocrinology.

[21]  Henry Buchwald,et al.  Bariatric surgery: a systematic review and meta-analysis. , 2004, JAMA.

[22]  Y. Liu,et al.  Functional significance of skeletal muscle adiponectin production, changes in animal models of obesity and diabetes, and regulation by rosiglitazone treatment. , 2009, American journal of physiology. Endocrinology and metabolism.

[23]  J S Yudkin,et al.  Journal of Clinical Endocrinology and Metabolism Printed in U.S.A. Copyright © 1997 by The Endocrine Society Subcutaneous Adipose Tissue Releases Interleukin-6, But Not Tumor Necrosis Factor-�, in Vivo* , 2022 .

[24]  W. Buurman,et al.  Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins, and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery. , 2004, The Journal of clinical endocrinology and metabolism.

[25]  M. Rubio,et al.  Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin. , 2008, The Journal of clinical endocrinology and metabolism.

[26]  C. Gutiérrez,et al.  Insulin resistance, leptin and TNF-alpha system in morbidly obese women after gastric bypass. , 2003, Obesity surgery.

[27]  C. Gutiérrez,et al.  Insulin Resistance, Leptin and TNF-α System in Morbidly Obese Women after Gastric Bypass , 2003 .

[28]  E. Wolf,et al.  The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL- 6 and prolongation of the plasma half-life of IL-6 , 1996, The Journal of experimental medicine.

[29]  B. Wolfe,et al.  Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery , 2008, Diabetologia.

[30]  K. Cianflone,et al.  Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects. , 2003, The Journal of clinical endocrinology and metabolism.

[31]  D. Wallach,et al.  Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors , 1992, The Journal of experimental medicine.

[32]  N. Luciani,et al.  Bariatric Surgery Can Correct Iron Depletion in Morbidly Obese Women: A Link with Chronic Inflammation , 2008, Obesity surgery.